Lopalco, A.; Manni, A.; Keeley, A.; Haider, S.; Li, W.; Lopedota, A.; Altomare, C.D.; Denora, N.; Tuleu, C.
In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics 2022, 14, 780.
https://doi.org/10.3390/pharmaceutics14040780
AMA Style
Lopalco A, Manni A, Keeley A, Haider S, Li W, Lopedota A, Altomare CD, Denora N, Tuleu C.
In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics. 2022; 14(4):780.
https://doi.org/10.3390/pharmaceutics14040780
Chicago/Turabian Style
Lopalco, Antonio, Annachiara Manni, Alexander Keeley, Shozeb Haider, Wenliang Li, Angela Lopedota, Cosimo Damiano Altomare, Nunzio Denora, and Catherine Tuleu.
2022. "In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use" Pharmaceutics 14, no. 4: 780.
https://doi.org/10.3390/pharmaceutics14040780
APA Style
Lopalco, A., Manni, A., Keeley, A., Haider, S., Li, W., Lopedota, A., Altomare, C. D., Denora, N., & Tuleu, C.
(2022). In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics, 14(4), 780.
https://doi.org/10.3390/pharmaceutics14040780
